About this episode

Experts review the treatment landscape of antibody-drug conjugate therapy for gynecologic cancers and discuss findings from the SGO 2026 Annual Meeting.

Prof Ramez N Eskander from UC San Diego Moores Cancer Center in California, Dr Bradley J Monk from Florida Cancer Specialists & Research Institute in West Palm Beach and Dr Kathleen N Moore from the Fred and Pamela Buffett Cancer Center in Omaha, Nebraska, review the treatment landscape of antibody-drug conjugate–directed therapy for gynecologic cancers and review recently presented clinical findings from the SGO 2026 Annual Meeting on Women’s Cancer. CME information and select publications

People in this episode

Host: Dr Neil Love

Guests: Prof Ramez N Eskander, Dr Bradley J Monk, Dr Kathleen N Moore

Topics covered

• antibody-drug conjugates
• gynecologic cancers
• clinical findings
• cancer treatment
• SGO Annual Meeting

Keywords

• antibody-drug conjugates
• gynecologic oncology
• cancer therapy
• clinical trials
• SGO 2026

Mentioned in this episode

Organizations: UC San Diego Moores Cancer Center, Florida Cancer Specialists & Research Institute, Fred and Pamela Buffett Cancer Center

More episodes of Gynecologic Oncology Update

• Ovarian Cancer — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women’s Cancer · May 21, 2026 · 1h 28m
• Immunotherapy for Endometrial Cancer — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women’s Cancer · May 14, 2026 · 1h 30m

Explore listener stats, chart rankings, contacts and more on the Gynecologic Oncology Update podcast page.